Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Net Income towards Common Stockholders (2020 - 2025)

Bio Essence (BIOE) has 6 years of Net Income towards Common Stockholders data on record, last reported at $12998.0 in Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders rose 110.76% year-over-year to $12998.0; the TTM value through Sep 2025 reached -$132890.0, down 122.07%, while the annual FY2024 figure was -$120827.0, 80.96% up from the prior year.
  • Net Income towards Common Stockholders reached $12998.0 in Q3 2025 per BIOE's latest filing, down from $59864.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $377752.0 in Q1 2024 and bottomed at -$633126.0 in Q3 2023.
  • Average Net Income towards Common Stockholders over 5 years is $59350.6, with a median of $164193.0 recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: surged 210.82% in 2022, then tumbled 417.78% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $90634.0 in 2021, then skyrocketed by 135.16% to $213133.0 in 2022, then surged by 61.99% to $345244.0 in 2023, then crashed by 135.0% to -$120827.0 in 2024, then soared by 110.76% to $12998.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were $12998.0 in Q3 2025, $59864.0 in Q2 2025, and -$205752.0 in Q1 2025.